FUT3

fucosyltransferase 3 (Lewis blood group), the group of Fucosyltransferases|CD molecules|Blood group antigens

Basic information

Region (hg38): 19:5842888-5851471

Previous symbols: [ "LE" ]

Links

ENSG00000171124NCBI:2525OMIM:111100HGNC:4014Uniprot:P21217AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Blood group, Lewis systemADHematologicVariants may be associated with a blood group may be important in specific situations (eg, related to transfusion)Hematologic2922027; 7961897; 8943285; 9703429; 11668626; 15383031

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the FUT3 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the FUT3 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
4
clinvar
2
clinvar
6
missense
32
clinvar
2
clinvar
2
clinvar
36
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 32 6 4

Variants in FUT3

This is a list of pathogenic ClinVar variants found in the FUT3 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
19-5843785-G-A not specified Uncertain significance (Nov 03, 2023)3097483
19-5843811-T-C Likely benign (Jul 06, 2018)783813
19-5843851-G-A not specified Likely benign (Mar 15, 2024)3280191
19-5843865-C-T FUT3-related disorder Benign (Mar 30, 2023)3044437
19-5843896-C-T not specified Uncertain significance (Jul 19, 2023)2591712
19-5843929-C-T not specified Likely benign (Jul 25, 2023)2595272
19-5843930-G-A not specified Uncertain significance (Mar 02, 2023)2493849
19-5843930-G-C not specified Uncertain significance (Feb 28, 2023)2468343
19-5843947-C-T not specified Uncertain significance (Dec 09, 2023)3097492
19-5844014-G-A not specified Uncertain significance (Sep 14, 2022)2369706
19-5844027-G-A FUT3-related disorder Likely benign (Dec 06, 2019)3354208
19-5844068-C-T not specified Uncertain significance (Jan 09, 2024)3097491
19-5844082-G-A not specified Uncertain significance (Dec 08, 2023)3097490
19-5844099-G-A FUT3-related disorder Likely benign (Mar 30, 2021)3030328
19-5844108-G-A Benign (Jun 12, 2018)718641
19-5844130-G-A not specified Uncertain significance (Dec 22, 2023)3097489
19-5844161-T-C not specified Uncertain significance (Oct 03, 2022)2350352
19-5844170-G-A not specified Uncertain significance (Jul 27, 2022)2403175
19-5844218-G-A not specified Uncertain significance (Jul 15, 2021)2237871
19-5844224-T-A not specified Uncertain significance (Dec 12, 2023)3097487
19-5844228-T-C FUT3-related disorder Likely benign (Jul 23, 2018)773080
19-5844244-T-C not specified Uncertain significance (May 20, 2024)3280189
19-5844270-G-A FUT3-related disorder Likely benign (Oct 26, 2022)3030791
19-5844310-C-T not specified Uncertain significance (May 23, 2024)3280192
19-5844322-T-C not specified Uncertain significance (Jul 09, 2021)2236076

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
FUT3protein_codingprotein_codingENST00000303225 18587
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.00006300.1631257380101257480.0000398
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.2592382271.050.00001632317
Missense in Polyphen6372.730.86622856
Synonymous-1.991301041.250.00000804761
Loss of Function-1.3952.591.931.13e-725

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00009040.0000904
Ashkenazi Jewish0.000.00
East Asian0.0001090.000109
Finnish0.000.00
European (Non-Finnish)0.00005270.0000527
Middle Eastern0.0001090.000109
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: May catalyze alpha-1,3 and alpha-1,4 glycosidic linkages involved in the expression of Vim-2, Lewis A, Lewis B, sialyl Lewis X and Lewis X/SSEA-1 antigens. May be involved in blood group Lewis determination; Lewis-positive (Le(+)) individuals have an active enzyme while Lewis-negative (Le(-)) individuals have an inactive enzyme. Also acts on the corresponding 1,4-galactosyl derivative, forming 1,3-L-fucosyl links.;
Pathway
Glycosphingolipid biosynthesis - lacto and neolacto series - Homo sapiens (human);Glycosphingolipid biosynthesis - lactoseries;Post-translational protein modification;Reactions specific to the complex N-glycan synthesis pathway;N-glycan antennae elongation in the medial/trans-Golgi;Metabolism of proteins;Transport to the Golgi and subsequent modification;Asparagine N-linked glycosylation (Consensus)

Recessive Scores

pRec
0.188

Intolerance Scores

loftool
0.628
rvis_EVS
2.6
rvis_percentile_EVS
98.77

Haploinsufficiency Scores

pHI
0.134
hipred
N
hipred_score
0.290
ghis

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.234

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumHigh
CancerMediumMediumMedium

Gene ontology

Biological process
protein glycosylation;ceramide metabolic process;oligosaccharide biosynthetic process;cell-cell recognition;fucosylation;macromolecule glycosylation
Cellular component
Golgi membrane;membrane;integral component of membrane;Golgi cisterna membrane;extracellular exosome
Molecular function
fucosyltransferase activity;3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity;alpha-(1->3)-fucosyltransferase activity